Geode Capital Management, LLC Co Diagnostics, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 345,511 shares of CODX stock, worth $172,755. This represents 0.0% of its overall portfolio holdings.
Number of Shares
345,511
Previous 321,275
7.54%
Holding current value
$172,755
Previous $401,000
35.41%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding CODX
# of Institutions
45Shares Held
5.59MCall Options Held
67.5KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA1.78MShares$889,0910.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$590,8160.1% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny556KShares$277,8110.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$251,0120.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$136,4500.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $16.9M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...